Literature DB >> 4033359

Differences between the tolerance characteristics of two anticonvulsant benzodiazepines.

J P Gent, M P Feely, J R Haigh.   

Abstract

Clobazam (10 mg/kg) and clonazepam (0.25 mg/kg) were administered to mice twice daily by the intraperitoneal route. The development of tolerance to their anticonvulsant effect was compared using a slow intravenous infusion of pentylenetetrazole as the convulsant stimulus. Tolerance to clonazepam developed gradually throughout a 72 h study and did not become significant until the fifth dose. In contrast, tolerance to clobazam occurred extremely rapidly, after only one dose; it was manifested as a single step and no further significant change in protection was observed. Recovery from benzodiazepine tolerance was also studied and seen to occur rapidly with both these compounds; following cessation of dosing, protection was restored to initial levels within 36-48 h.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4033359     DOI: 10.1016/0024-3205(85)90520-x

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  10 in total

1.  Glutamic acid decarboxylase and glutamate receptor changes during tolerance and dependence to benzodiazepines.

Authors:  E Izzo; J Auta; F Impagnatiello; C Pesold; A Guidotti; E Costa
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

Review 2.  Modulation and polytypic signaling in GABAergic transmission.

Authors:  J L Schlichting
Journal:  Neurochem Res       Date:  1990-02       Impact factor: 3.996

3.  Lack of anticonvulsant tolerance and benzodiazepine receptor down regulation with imidazenil in rats.

Authors:  A Zanotti; R Mariot; A Contarino; M Lipartiti; P Giusti
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

4.  Proceedings of the British Pharmacological Society. Leeds, 12th-14th July 1989. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

5.  Disappointing results of increasing benzodiazepine dose after the development of anticonvulsant tolerance.

Authors:  J R Haigh; J P Gent; J C Garratt; T Pullar; M Feely
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-07       Impact factor: 10.154

6.  Peripheral benzodiazepine receptors in platelets of epileptic patients.

Authors:  J G Larkin; P J McKee; G G Thompson; M J Brodie
Journal:  Br J Clin Pharmacol       Date:  1993-07       Impact factor: 4.335

7.  Chronic benzodiazepine administration. VII. Behavioral tolerance and withdrawal and receptor alterations associated with clonazepam administration.

Authors:  W R Galpern; M Lumpkin; D J Greenblatt; R I Shader; L G Miller
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

8.  N-desmethylclobazam: a possible alternative to clobazam in the treatment of refractory epilepsy?

Authors:  J R Haigh; T Pullar; J P Gent; C Dailley; M Feely
Journal:  Br J Clin Pharmacol       Date:  1987-02       Impact factor: 4.335

9.  Effects of clobazam and clonazepam on saccadic eye movements and other parameters of psychomotor performance.

Authors:  C H van der Meyden; P R Bartel; D K Sommers; M Blom; L C Pretorius
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

10.  Characterization of [3H]-imidazenil binding to rat brain membranes.

Authors:  M Lipartiti; R Arban; E Fadda; A Zanotti; P Giusti
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.